UBS Lam Research · LRCX

UBS Lowers Lam Research Price Target to $400

October 22, 2026 Analyst: Timothy Arcuri 1 min read Reproduced verbatim
Rating
Buy
Target
$400
from $425 (−6%)
Upside
+72%
LRCX at $233 today
UBS and Lam Research logos

What the analyst said

UBS analyst Timothy Arcuri lowered the price target on Lam Research (NASDAQ: LRCX) to $400 (from $425) while maintaining a Buy rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

LRCX trades at $233. The 9 analysts who set a target in the last 3 months range from $290 to $400, with a median of $350. This $400 target is 14% above the median, the highest on the Street.

12-month window: day 1 of 365, closes on October 22, 2027.

Track record

This callOpen: LRCX has not reached $400 yet. This 12-month target is scored on October 22, 2027.

Firm track recordUBS: 83% of its 30 targets at least a year old were reached within 12 months (#13 of 28 firms). Accuracy ranking →

Earnings reactionOne of 6 notes after Lam Research’s Oct 21 results: 6 of 6 cut targets. See every call →

UBS on Lam Research

UBS price targets on Lam Research

8 calls from January 20, 2026 to October 22, 2026. The target went from $255 to $400 (+57%). The rating stayed Buy.

UBS targetLRCX share price
  1. October 22, 2026 This noteTarget cut from $425 (−6%)Buy$400
  2. September 1, 2026Target cut from $435 (−2%)Buy$425
  3. July 15, 2026Target raised from $375 (+16%)Buy$435
  4. June 9, 2026Target raised from $310 (+21%)Buy$375
  5. April 23, 2026Kept the $310 targetBuy$310
  6. April 13, 2026Target raised from $275 (+13%)Buy$310
  7. January 29, 2026Target raised from $255 (+8%)Buy$275
  8. January 20, 2026Earliest call shownBuy$255
Share

Other analysts on Lam Research

BernsteinBuy Cut price target −9%, kept rating · Oct 22 $350from $385 Morgan StanleyBuy Cut price target −12%, kept rating · Oct 22 $339from $385 Bank of AmericaBuy Cut price target −10%, kept rating · Oct 22 $345from $385 NeedhamBuy Cut price target −26%, kept rating · Oct 22 $290from $390 MizuhoBuy Cut price target −1%, kept rating · Oct 22 $360from $365
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.